Sponsor Pipeline

Dr. Falk Pharma GmbH Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
3
Phase 3
Active Trials by Phase
Phase 3
3
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06596252 Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of… Eosinophilic Esophagitis Recruiting
NCT03872921 norUrsodeoxycholic Acid vs Placebo in PSC Primary Sclerosing Cholangitis Active, Not Recruiting
NCT06886360 Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC) Primary Sclerosing Cholangitis Not Yet Recruiting
Phase 2
NCT07298343 Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive… Celiac Disease Recruiting
Get alerts when Dr. Falk Pharma GmbH's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free